JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

Search

McKesson Corp

Open

BrancheGesundheitswesen

833.62 1.3

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

822.13

Max

841.29

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

1.3B

Verkäufe

3B

106B

KGV

Branchendurchschnitt

24.813

60.328

Dividendenrendite

0.35

Gewinnspanne

1.177

Angestellte

43,000

EBITDA

374M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+18.33% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.35%

2.24%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Juli 2026

Nächstes Ex-Dividendendatum

1. Juni 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

736M

106B

Vorheriger Eröffnungskurs

832.32

Vorheriger Schlusskurs

833.62

Nachrichtenstimmung

By Acuity

34%

66%

107 / 348 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

27. Apr. 2026, 23:15 UTC

Wichtige Nachrichtenereignisse

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27. Apr. 2026, 23:08 UTC

Ergebnisse
Wichtige Markttreiber

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27. Apr. 2026, 23:58 UTC

Ergebnisse

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27. Apr. 2026, 23:58 UTC

Ergebnisse

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27. Apr. 2026, 23:56 UTC

Ergebnisse

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27. Apr. 2026, 23:56 UTC

Ergebnisse

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27. Apr. 2026, 23:48 UTC

Market Talk

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27. Apr. 2026, 23:42 UTC

Market Talk

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27. Apr. 2026, 23:34 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27. Apr. 2026, 23:30 UTC

Market Talk

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27. Apr. 2026, 23:08 UTC

Market Talk

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27. Apr. 2026, 23:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27. Apr. 2026, 23:02 UTC

Market Talk

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27. Apr. 2026, 22:42 UTC

Market Talk

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27. Apr. 2026, 22:10 UTC

Ergebnisse

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27. Apr. 2026, 22:09 UTC

Ergebnisse

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27. Apr. 2026, 22:09 UTC

Ergebnisse

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27. Apr. 2026, 22:09 UTC

Ergebnisse

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27. Apr. 2026, 21:56 UTC

Ergebnisse

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27. Apr. 2026, 21:55 UTC

Ergebnisse

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27. Apr. 2026, 21:55 UTC

Ergebnisse

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27. Apr. 2026, 21:44 UTC

Ergebnisse

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27. Apr. 2026, 21:43 UTC

Ergebnisse

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27. Apr. 2026, 21:41 UTC

Ergebnisse

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27. Apr. 2026, 21:41 UTC

Ergebnisse

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27. Apr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27. Apr. 2026, 20:50 UTC

Market Talk
Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

27. Apr. 2026, 20:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

27. Apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27. Apr. 2026, 20:39 UTC

Ergebnisse

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

18.33% Vorteil

12-Monats-Prognose

Durchschnitt 979.89 USD  18.33%

Hoch 1,107 USD

Tief 885 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

107 / 348 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat